Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Aortic Interventions: Features

When and How to Treat Patients With Genetic Aortic Disorders by Endovascular Aortic Techniques
Meeting Exclusives
When and How to Treat Patients With Genetic Aortic Disorders by Endovascular Aortic Techniques
01/30/2020
Tilo Kölbel, MD (German Aortic Centre, University Heart Centre Hamburg, Germany) questions the dogma that rejects the use of endovascular treatment of connective tissue disorders, during a session on the latest techniques for endovascular...
Tilo Kölbel, MD (German Aortic Centre, University Heart Centre Hamburg, Germany) questions the dogma that rejects the use of endovascular treatment of connective tissue disorders, during a session on the latest techniques for endovascular...
Tilo Kölbel, MD (German Aortic...
01/30/2020
Vascular Disease Management
Challenges in Treating Aortic Occlusive Disease
Interview
Challenges in Treating Aortic Occlusive Disease
01/21/2020
Vascular Disease Management spoke with Daniel Clair, MD, about challenges in treating aortic occlusive disease, upcoming clinical trials, and a case-based discussion at ISET.
Vascular Disease Management spoke with Daniel Clair, MD, about challenges in treating aortic occlusive disease, upcoming clinical trials, and a case-based discussion at ISET.
Vascular Disease Management...
01/21/2020
Vascular Disease Management
Valiant Navion Meets Safety and Effectiveness Endpoints
Interview
Valiant Navion Meets Safety and Effectiveness Endpoints
01/17/2020
Vascular Disease Management talks with Ali Azizzadeh, MD, Professor and Director of the Division of Vascular Surgery, Cedars-Sinai Medical Center and U.S. principal investigator for the Valiant Navion IDE study.
Vascular Disease Management talks with Ali Azizzadeh, MD, Professor and Director of the Division of Vascular Surgery, Cedars-Sinai Medical Center and U.S. principal investigator for the Valiant Navion IDE study.
Vascular Disease Management...
01/17/2020
Vascular Disease Management
Case Report
Hybrid Approach for Treatment of Middle Aortic Syndrome: Multidisciplinary Teamwork
11/20/2019
Researchers report one of the first successful cases of a hybrid surgical and interventional approach to treat middle aortic syndrome in a 22-month-old infant, using re-expandable stents to avoid the need for further interventions.
Researchers report one of the first successful cases of a hybrid surgical and interventional approach to treat middle aortic syndrome in a 22-month-old infant, using re-expandable stents to avoid the need for further interventions.
Researchers report one of the...
11/20/2019
Vascular Disease Management
Case Report
Rare Image of a Patent Axillopopliteal PTFE Graft Bypass With Postoperative 3D-Reconstructed Angiogram
12/13/2018
Computed tomographic angiography has become a helpful tool for identifying potential complications of bypass grafting and for planning further therapy in a quick and non-invasive manner.
Computed tomographic angiography has become a helpful tool for identifying potential complications of bypass grafting and for planning further therapy in a quick and non-invasive manner.
Computed tomographic angiography...
12/13/2018
Vascular Disease Management
Case Report
Causes and Management of Failing Unibody EVAR Grafts
11/21/2018
Patients treated with the lower-profile AFX Strata endograft have an increased risk of type III endoleak which may be treated with relining, according to a case report.
Patients treated with the lower-profile AFX Strata endograft have an increased risk of type III endoleak which may be treated with relining, according to a case report.
Patients treated with the...
11/21/2018
Vascular Disease Management
Interview
Decades of EVAR: Are We Making Progress?
09/11/2018
Frank J. Criado, MD, FACS, FSVM, spoke about endovascular aneurysm repair at the 2018 International Symposium on Endovascular Therapy.
Frank J. Criado, MD, FACS, FSVM, spoke about endovascular aneurysm repair at the 2018 International Symposium on Endovascular Therapy.
Frank J. Criado, MD, FACS, FSVM,...
09/11/2018
Vascular Disease Management
Case Report
Transcatheter Closure of Residual Aortopulmonary Window With Amplatzer Duct Occluder II in an Infant
02/22/2018
An 11-month-old boy weighing 9.8 kg was admitted to our department with a postsurgical residual aortopulmonary window.
An 11-month-old boy weighing 9.8 kg was admitted to our department with a postsurgical residual aortopulmonary window.
An 11-month-old boy weighing 9.8...
02/22/2018
Vascular Disease Management
Case Report
Trans-Subclavian Implantation of the Acurate Neo Transcatheter Aortic Prosthesis
02/08/2018
Severe iliofemoral arteriopathies precludes transfemoral access in approximately one-third of patients, but subclavian access represents an alternative option for these patients.
Severe iliofemoral arteriopathies precludes transfemoral access in approximately one-third of patients, but subclavian access represents an alternative option for these patients.
Severe iliofemoral...
02/08/2018
Vascular Disease Management
Editor's Corner
Avoiding Peripheral Vascular Complications With Large Bore Devices
01/24/2018
Dr. Walker comments on Poli and colleagues’ article on the implantation of the ACURATE neo transcatheter aortic valve to treat a patient with severe aortic stenosis via a subclavian artery that was surgically exposed.
Dr. Walker comments on Poli and colleagues’ article on the implantation of the ACURATE neo transcatheter aortic valve to treat a patient with severe aortic stenosis via a subclavian artery that was surgically exposed.
Dr. Walker comments on Poli and...
01/24/2018
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement